Peter Heerma insider trades

Open-market stock purchases and sales by Peter Heerma, EVP, CHIEF COMMERCIAL OFFICER at Travere Therapeutics, Inc, from SEC Form 4 filings since Oct 1, 2019.

Recent trades

DateStockTradeValue
Sep 17, 2026TVTX Travere Therapeutics, IncSold$539K
Sep 17, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Sep 16, 2026TVTX Travere Therapeutics, IncSold$5.9M
Sep 16, 2026TVTX Travere Therapeutics, IncSold$5M
Sep 16, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Sep 16, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Sep 16, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Sep 15, 2026TVTX Travere Therapeutics, IncSold$4.5M
Sep 15, 2026TVTX Travere Therapeutics, IncSold$1.7M
Sep 15, 2026TVTX Travere Therapeutics, IncSold$89.1K
Sep 15, 2026TVTX Travere Therapeutics, IncSold$93.5K
Sep 15, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Sep 15, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Sep 15, 2026TVTX Travere Therapeutics, IncBought (not open market)—
May 5, 2026TVTX Travere Therapeutics, IncSold$101K
May 4, 2026TVTX Travere Therapeutics, IncBought (not open market)—
May 4, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Apr 14, 2026TVTX Travere Therapeutics, IncSold$303K
Apr 13, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Feb 3, 2026TVTX Travere Therapeutics, IncSold$235K
Jan 31, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Jan 31, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Dec 24, 2025TVTX Travere Therapeutics, IncSold$199K
Nov 3, 2025TVTX Travere Therapeutics, IncSold (not open market)—
Oct 31, 2025TVTX Travere Therapeutics, IncSold$196K

Companies traded

  • TVTX Travere Therapeutics, Inc: 33 sales, last Sep 17, 2026
  • RTRX Retrophin, Inc: 2 sales, last Oct 5, 2020

Get free alerts when Peter Heerma files a new trade →